Association of thyroid-stimulating hormone levels and body mass index in overweight Hispanics in Puerto Rico

Graduate Department, Clinical Laboratory Science Program, School of Health Professions, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico, USA.
Ethnicity & disease (Impact Factor: 1). 03/2008; 18(2 Suppl 2):S2-151-4.
Source: PubMed


Obesity is a serious public health problem, and the increasing prevalence of overweight status in the population is a major concern worldwide. Fifty eight percent of the Hispanic population of Puerto Rico is obese, but no data are available regarding thyroid status and body mass index (BMI) in this Hispanic group. This study was conducted to investigate if a relationship existed between obesity and thyroid function, as measured by thyroid-stimulating hormone (TSH) levels on a group of Hispanics enrolled in a weight control clinic in Puerto Rico.
We conducted a retrospective analysis of 637 clinical files of patients enrolled at Doctors Weight Loss Center. Five hundred seventy-five patients were eligible for this study. Inclusion criteria were adults > or = 21 years of age with data for age, sex, height, weight, percentage fat, and TSH values.
Prevalence of subclinical or mild hypothyroidism (TSH > 4.1 mU/L), as per American Thyroid Association definitions, was 8.2% in our study group, which is higher than reported in the National Health and Nutrition Examination Survey (NHANES). Another 18.2% were in the at-risk category (TSH 2.51-4.0 mU/L).
We found no association between thyroid status and overweight or obesity in this study group but found a higher prevalence of subclinical hypothyroidism compared to the prevalence reported in NHANES.

Download full-text


Available from: Himilce Velez,
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is associated with significant alterations in endocrine function. An association with type 2 diabetes mellitus and dyslipidemia has been well documented. This article highlights the complexities of treating endocrine system disorders in obese patients.
    Critical care clinics 10/2010; 26(4):633-6. DOI:10.1016/j.ccc.2010.06.002 · 2.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Subclinical hypothyroidism (SH) is a frequent condition affecting millions of people around the world. Defined by increased thyrotropin-stimulating hormone (TSH) and accompanied by normal thyroid hormone levels, SH reflects a mild tissue hypothyroidism that has been associated with metabolic derangements and-although this issue is still contentious-possibly with increased cardiovascular risk. Depending on the degree of TSH elevation, SH has accordingly been associated with hyperlipidemia, arterial hypertension, and cardiovascular disease (CVD), as well as, increasingly, newly emerging CVD risk factors such as serum C-reactive protein and retinol binding protein 4 levels. There have also been reports of abnormalities in glucose metabolism and of hemostatic parameters, mainly underscored by the increased activity of factor VII. This review discusses the results of the latest studies on the various parameters affected by SH while highlighting the need for timely treatment with levothyroxine.
    Seminars in Thrombosis and Hemostasis 02/2011; 37(1):27-34. DOI:10.1055/s-0030-1270068 · 3.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Thyroid cancer incidence has risen dramatically in the United States since the early 1980s. Although the prevalence of obesity has doubled during this time period, the relationship between obesity and thyroid cancer is uncertain. We examined the association between body mass index (BMI) and thyroid cancer risk in a pooled analysis of five prospective U.S. studies, including 413,979 women and 434,953 men. Proportional hazards models with attained age as the time metric were adjusted for education, race, marital status, smoking, alcohol intake, and (where appropriate) cohort and sex. Over follow-up (mean=10.3 years), 768 women and 388 men were diagnosed with thyroid cancer. The risk of thyroid cancer was greater with increasing BMI [per 5 kg/m2: HR in women, 1.16 (95% CI, 1.08-1.24); HR in men, 1.21 (95% CI, 0.97-1.49)]. There was no significant heterogeneity between studies (both P>0.05). For women and men combined, the HRs for overweight (25.0-29.9 kg/m2) and obesity (≥30 kg/m2) compared with normal-weight (18.5-24.9 kg/m2) were 1.20 (95% CI, 1.04-1.38) and 1.53 (95% CI, 1.31-1.79), respectively. We found no significant effect modification by other factors, and the results did not differ significantly by histologic type. A significant positive association for BMI in young adulthood (ages 18-20) with thyroid cancer risk was also observed [per 5-kg/m2 increase: HR, 1.18 (95% CI, 1.03-1.35)]. BMI was positively associated with thyroid cancer risk in both men and women. Our study provides strong evidence that obesity is an independent risk factor for thyroid cancer.
    Cancer Epidemiology Biomarkers & Prevention 03/2011; 20(3):464-72. DOI:10.1158/1055-9965.EPI-10-1220 · 4.13 Impact Factor
Show more